Vous êtes ici : Accueil > Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes

publications-2011-2015

Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes

Publié le 19 mars 2015
Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes
Auteurs
Le Pogam C, Krief P, Beurlet S, Soulie A, Balitrand N, Cassinat B, Cave H, Kosmider O, Setterblad N, Leboeuf C, Sarda-Mantel L, Hervatin F, Merlet P, Noguera ME, Janin A, Pla M, Fontenay M, Ades L, Fenaux P, Chomienne C, Padua RA, Omidvar N
Revue
InstitutI2BM
Année2 013

Go back to list